诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301201 诚达药业

已收盘 11-13 15:00:00

{"stockData":{"symbol":"301201","market":"SZ","secType":"STK","nameCN":"诚达药业","latestPrice":23.26,"timestamp":1794553419000,"preClose":24.16,"halted":0,"volume":3254800,"delay":0,"changeRate":-0.0373,"floatShares":109000000,"shares":155000000,"eps":-0.2659,"marketStatus":"已收盘","change":-0.9,"latestTime":"11-13 15:00:00","open":24.33,"high":24.71,"low":23.22,"amount":77350500,"amplitude":0.0617,"askPrice":23.37,"askSize":8,"bidPrice":23.26,"bidSize":101,"shortable":0,"etf":0,"ttmEps":-0.2659,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":24.16,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":26.58,"lowLimit":21.74,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":154713824,"isCdr":false,"pbRate":1.82,"roa":"--","roe":"--","epsLYR":-0.0787,"committee":0.225152,"marketValue":3599000000,"turnoverRate":0.03,"status":1,"floatMarketCap":2525000000},"requestUrl":"/m/hq/s/301201","defaultTab":"news","newsList":[{"id":"2681765884","title":"诚达药业：公司IPO募集资金包括超募资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2681765884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681765884?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:52","pubTimestamp":1793926325,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业(301201)11月05日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，想咨询两个问题：1、公司IPO阶段是否存在超募资金？2、近期护盘式回购相关新规征求意见，公司目前股价长期处于发行价下方，结合新规方向，公司是否会考虑推出以股份注销为目的的回购方案，维护二级市场投资者利益？诚达药业回复：尊敬的投资者您好！公司IPO募集资金包括超募资金。公司按照相关法律法规的规定做好超募资金的存放、管理与使用。感谢您的建议与关注，应披露信息请以公司公告为准。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681767884","title":"诚达药业：2026年前三季度募投项目新车间的折旧摊销总额为2,729.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681767884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681767884?lang=zh_cn&edition=full","pubTime":"2026-11-06 08:52","pubTimestamp":1793926324,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业11月05日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600008812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679242902","title":"诚达药业（301201）2026年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2679242902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679242902?lang=zh_cn&edition=full","pubTime":"2026-10-31 03:12","pubTimestamp":1793387569,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诚达药业发布2026年三季报。根据财报显示，诚达药业增收不增利。截至本报告期末，公司营业总收入3.56亿元，同比上升24.76%，归母净利润-1242.77万元，同比下降174.09%。本文数据来源于诚达药业2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100004796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678179658","title":"图解诚达药业三季报：第三季度单季净利润同比下降472.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678179658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678179658?lang=zh_cn&edition=full","pubTime":"2026-10-27 19:10","pubTimestamp":1793099429,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业2026年三季报显示，前三季度公司主营收入3.56亿元，同比上升24.76%；归母净利润-1242.77万元，同比下降174.09%；扣非净利润-2211.9万元，同比下降666.78%；其中2026年第三季度，公司单季度主营收入1.0亿元，同比下降2.38%；单季度归母净利润-1472.74万元，同比下降472.94%；单季度扣非净利润-1684.64万元，同比下降1778.73%；负债率11.84%，投资收益-247.01万元，财务费用478.2万元，毛利率30.13%。财报数据概要请见下图:本文数据来源于诚达药业2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700036507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678277901","title":"诚达药业(301201.SZ)发布前三季度业绩，归母净亏损1242.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678277901","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678277901?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:53","pubTimestamp":1793094836,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诚达药业(301201.SZ)发布2026年三季度报告，前三季度，公司实现营业收入3.56亿元，同比增长24.76%。归属于上市公司股东净亏损1242.77万元。归属于上市公司股东的扣除非经常性损益净亏损2211.9万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675587910","title":"诚达药业：该项目为公司的植物源胆固醇原料药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2675587910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675587910?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:51","pubTimestamp":1792068702,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：在诚达药业2022年年报里，有一条研发项目非常扎眼：NP2221--“应用于制备脂质纳米颗粒系统、mRNA疫苗、维生素D及其衍生物的原料药研究”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500037542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670728249","title":"诚达药业：公司小核酸业务主要为亚磷酰胺单体和GalNAc递送系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2670728249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670728249?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:45","pubTimestamp":1790581513,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业09月28日在投资者关系平台上答复投资者关心的问题。另外公司是否有基因合成中所需的最重要的原料亚磷酰胺。公司目前小核酸业务主要为亚磷酰胺单体和GalNAc递送系统，开发的亚磷酰胺单体种类有十余种，公司也会根据市场及客户需要提供修饰单体的工艺开发和生产，满足小核酸药物的定制化生产需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800016049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669103430","title":"诚达药业：2025年海外收入同比2024年增加33.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669103430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669103430?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:09","pubTimestamp":1790212172,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业(301201)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司今年海外业务占比多少？前两年为何海外业务占比持续收缩？诚达药业回复：尊敬的投资者您好！关于2026年具体业绩情况请关注公司后续的定期报告；按定期报告中分地区的收入统计口径，公司2025年海外收入同比2024年增加33.29%，占营业收入的比重由2024年的32.91%增加至35.96%。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669810686","title":"破发股诚达药业跌11.54% 上市超募11亿光大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2669810686","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669810686?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:47","pubTimestamp":1790149623,"startTime":"0","endTime":"0","summary":"中国经济网北京9月23日讯 诚达药业 今日收报32.81元，跌幅11.54%。　　诚达药业于2022年1月20日在深交所创业板上市，公开发行新股2,417.4035万股，发行价格为72.69元/股，保荐机构为光大证券，保荐代表人为杨科、范国祖。　　上市首日，诚达药业盘中最高报188.00元，为该股上市以来最高点。　　诚达药业首次公开发行股票发行费用总额为13,576.31万元，其中，保荐承销费用11,792.90万元。　　诚达药业于2023年7月3日披露分红方案，每10股转增6股，派息(税前)3元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260923/32378961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0012","BK0188","IPOS","06178","BK0183","BK1147","BK1564","301201","BK0276","601788","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665236274","title":"股市必读：9月4日诚达药业现1笔折价17.99%的大宗交易 合计成交2122.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665236274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665236274?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:17","pubTimestamp":1788715028,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，诚达药业报收于35.36元，下跌1.59%，换手率4.24%，成交量4.61万手，成交额1.66亿元。当日关注点交易信息汇总：9月4日主力资金净流入298.21万元，占总成交额1.8%；  交易信息汇总：9月4日发生1笔折价17.99%的大宗交易，合计成交2122.19万元。大宗交易9月4日诚达药业发生1笔大宗交易，折价17.99%，成交金额2122.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664433879","title":"9月4日诚达药业现1笔折价17.99%的大宗交易 合计成交2122.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664433879","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664433879?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:27","pubTimestamp":1788514073,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日诚达药业发生大宗交易，交易数据如下：大宗交易成交价格29元，相对当日收盘价折价17.99%，成交73.18万股，成交金额2122.19万元，买方营业部为银泰证券有限责任公司深圳金田路证券营业部，卖方营业部为财通证券股份有限公司深圳后海滨路证券营业部。近三个月该股共发生12笔大宗交易，合计成交7.72万手，折价成交12笔。截至2026年9月4日收盘，诚达药业报收于35.36元，下跌1.59%，换手率4.24%，成交量4.61万手，成交额1.66亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400030403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050304","title":"破发股诚达药业跌4.82% 上市超募11亿光大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050304","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662050304?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:13","pubTimestamp":1787904781,"startTime":"0","endTime":"0","summary":"中国经济网北京8月28日讯 诚达药业 今日收报34.59元，跌幅4.82%。　　诚达药业于2022年1月20日在深交所创业板上市，公开发行新股2,417.4035万股，发行价格为72.69元/股，保荐机构为光大证券，保荐代表人为杨科、范国祖。　　上市首日，诚达药业盘中最高报188.00元，为该股上市以来最高点。　　诚达药业首次公开发行股票发行费用总额为13,576.31万元，其中，保荐承销费用11,792.90万元。　　诚达药业于2023年7月3日披露分红方案，每10股转增6股，派息(税前)3元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260828/32351786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1147","301201","IPOS","BK0028","06178","BK1564","BK0276","BK0012","BK0188","601788","BK0183","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662592749","title":"股市必读：诚达药业新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662592749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662592749?lang=zh_cn&edition=full","pubTime":"2026-08-27 02:20","pubTimestamp":1787768434,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告摘要显示，公司实现营业收入255,491,382.80元，同比增长40.03%，但归属于上市公司股东的净利润同比下降82.07%至2,299,706.82元。公司公告汇总2026年半年度报告摘要诚达药业股份有限公司发布2026年半年度报告摘要。2026年半年度非经营性资金占用及其他关联资金往来情况汇总表诚达药业股份有限公司披露2026年半年度非经营性资金占用及其他关联资金往来情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700006842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662559764","title":"诚达药业扣非连亏2年半 上市超募11亿光大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2662559764","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662559764?lang=zh_cn&edition=full","pubTime":"2026-08-26 11:36","pubTimestamp":1787715363,"startTime":"0","endTime":"0","summary":"中国经济网北京8月26日讯 诚达药业 昨晚发布2026年半年报，今年上半年，公司营业收入为2.55亿元，同比增长40.03%；归属于上市公司股东的净利润为229.97万元，同比下降82.07%；归属于上市公司股东的扣非净利润为-527.26万元，同比下降281.87%；经营活动产生的现金流量净额为4323.36万元。　　诚达药业首次公开发行股票发行费用总额为13,576.31万元，其中，保荐承销费用11,792.90万元。　　诚达药业于2023年7月3日披露分红方案，每10股转增6股，派息(税前)3元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/26/20260826915548.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/26/20260826915548.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260826/32347704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0276","BK1147","IPOS","06178","BK1564","301201","BK0028","601788","BK0183","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662589357","title":"诚达药业（301201）披露2026年半年度报告，8月25日股价上涨8.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662589357","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662589357?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:12","pubTimestamp":1787667179,"startTime":"0","endTime":"0","summary":"近日，诚达药业股份有限公司发布2026年半年度报告摘要。报告期内，公司实现营业收入255,491,382.80元，较上年同期增长40.03%；归属于上市公司股东的净利润为2,299,706.82元，同比下降82.07%；扣除非经常性损益后的净利润为-5,272,563.49元，同比减少281.87%。截至报告期末，公司总资产为2,350,661,974.39元，较上年度末增长0.03%；归属于上市公司股东的净资产为2,096,743,312.24元，较上年度末增长0.11%。公司控股股东及实际控制人在报告期内未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662380707","title":"诚达药业(301201)6月30日股东户数1.61万户，较上期增加12.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662380707","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662380707?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:57","pubTimestamp":1787651844,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诚达药业披露，截至2026年6月30日公司股东户数为1.61万户，较3月31日增加1848.0户，增幅为12.93%。在医疗服务行业个股中，诚达药业股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.77万户。从股价来看，2026年3月31日至2026年6月30日，诚达药业区间跌幅为29.67%，在此期间股东户数增加1848.0户，增幅为12.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662590787","title":"诚达药业(301201.SZ)发布上半年业绩，归母净利润229.97万元，同比下降82.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662590787","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662590787?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:50","pubTimestamp":1787647843,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诚达药业 发布2026年半年度报告，报告期内，公司实现营业收入2.55亿元，同比增长40.03%。实现归属于上市公司股东的净利润229.97万元，同比下降82.07%。归属于上市公司股东的扣除非经常性损益净亏损527.26万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"诚达药业(301201.SZ)发布上半年业绩，归母净利润229.97万元，同比下降82.07%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661426683","title":"破发股诚达药业跌7.66% 上市超募11亿光大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426683","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661426683?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:54","pubTimestamp":1787302446,"startTime":"0","endTime":"0","summary":"中国经济网北京8月21日讯 诚达药业 今日收报35.80元，跌幅7.66%。　　诚达药业于2022年1月20日在深交所创业板上市，公开发行新股2,417.4035万股，发行价格为72.69元/股，保荐机构为光大证券，保荐代表人为杨科、范国祖。　　上市首日，诚达药业盘中最高报188.00元，为该股上市以来最高点。　　诚达药业首次公开发行股票发行费用总额为13,576.31万元，其中，保荐承销费用11,792.90万元。　　诚达药业于2023年7月3日披露分红方案，每10股转增6股，派息(税前)3元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260821/32342833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601788","BK0276","301201","BK0239","BK0188","BK0012","BK0028","IPOS","06178","BK1147","BK0183","BK1564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658876920","title":"破发股诚达药业跌10.49% 上市超募11亿光大证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2658876920","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658876920?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:29","pubTimestamp":1786523347,"startTime":"0","endTime":"0","summary":"中国经济网北京8月12日讯 诚达药业 今日收报35.75元，跌幅10.49%。　　诚达药业于2022年1月20日在深交所创业板上市，公开发行新股2,417.4035万股，发行价格为72.69元/股，保荐机构为光大证券，保荐代表人为杨科、范国祖。　　上市首日，诚达药业盘中最高报188.00元，为该股上市以来最高点。　　诚达药业首次公开发行股票发行费用总额为13,576.31万元，其中，保荐承销费用11,792.90万元。　　诚达药业于2023年7月3日披露分红方案，每10股转增6股，派息(税前)3元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260812/32332800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","06178","301201","601788","BK0276","BK0183","BK1147","BK1564","BK0188","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657683969","title":"诚达药业：2026年一季度扣非净利润较上年同期实现转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2657683969","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657683969?lang=zh_cn&edition=full","pubTime":"2026-08-06 15:36","pubTimestamp":1786001768,"startTime":"0","endTime":"0","summary":"证券之星消息，诚达药业08月06日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600020796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794572412339,"stockEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":-0.1729},{"period":"3month","weight":-0.3429},{"period":"6month","weight":-0.3768},{"period":"1year","weight":-0.3235},{"period":"ytd","weight":-0.4032}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0382},{"period":"3month","weight":-0.0691},{"period":"6month","weight":-0.116},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.0789}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诚达药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16432人(较上一季度增加1.79%)","perCapita":"6605股","listingDate":"2022-01-20","address":"浙江省嘉兴市嘉善县惠民街道黄河路36号","registeredCapital":"15471万元","survey":"　　诚达药业股份有限公司的主营业务是为跨国制药企业及医药研发机构提供关键医药中间体,原料药CDMO研发生产服务，左旋肉碱系列产品,原料药的研发,生产和销售以及干细胞药物的研发。公司的主要产品是利伐沙班、艾拉戈克钠、布立西坦、左卡尼汀、UMC01细胞注射液、(S)-2-(1-溴-8-氨基咪唑并[1,5-a]吡嗪-3-基)吡咯烷-1-羧酸苄酯、4-(2-吡啶基氨甲酰基)苯硼酸、3-硝基-4-[[(四氢-2H-吡喃-4-基)甲基]氨基]苯磺酰胺、1-{[2-（4-氯苯基）-4,4-二甲基-1-环己烯-1-基]甲基}哌嗪二盐酸。","listedPrice":72.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诚达药业,301201,诚达药业股票,诚达药业股票老虎,诚达药业股票老虎国际,诚达药业行情,诚达药业股票行情,诚达药业股价,诚达药业股市,诚达药业股票价格,诚达药业股票交易,诚达药业股票购买,诚达药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}